4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

7 API Suppliers, 4 USDMF, 1 NDC API, 5 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 1 Canada

DIGITAL CONTENT

3 NEWS #PharmaBuzz

3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 1 US Exclusivities

Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1GALDERMA LABS LP

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

GALDERMA LABS LP

euroPLX 86 Munich

Not Confirmed

Contact us
to update this info